Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A5,2 | Lung | Primary cancer | 4,071 | Tumor/Malignant | 34.7% | 0.48 | 0.87 |
| NSCLC_38242124__IMC__88_A5,3 | Lung | Primary cancer | 4,953 | Immune | 35.5% | 0.92 | 0.23 |
| NSCLC_38242124__IMC__88_A5,4 | Lung | Primary cancer | 2,985 | Stromal | 37.8% | 0.85 | 0.41 |
| NSCLC_38242124__IMC__88_A5,5 | Lung | Primary cancer | 1,331 | Stromal | 27.8% | 0.61 | 0.79 |
| NSCLC_38242124__IMC__88_A5,6 | Lung | Primary cancer | 2,916 | Immune | 49.9% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_A5,8 | Lung | Primary cancer | 4,174 | Tumor/Malignant | 36.7% | 0.76 | 0.53 |
| NSCLC_38242124__IMC__88_A5,9 | Lung | Primary cancer | 2,590 | Tumor/Malignant | 80.8% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_A6,1 | Lung | Primary cancer | 4,214 | Tumor/Malignant | 43.1% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__88_A6,10 | Lung | Primary cancer | 2,671 | Tumor/Malignant | 72.0% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__88_A6,11 | Lung | Primary cancer | 3,657 | Tumor/Malignant | 68.9% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_A6,12 | Lung | Primary cancer | 3,303 | Tumor/Malignant | 47.8% | 0.96 | 0.18 |
| NSCLC_38242124__IMC__88_A6,13 | Lung | Primary cancer | 816 | Stromal | 33.6% | 0.85 | 0.42 |
| NSCLC_38242124__IMC__88_A6,15 | Lung | Primary cancer | 3,624 | Tumor/Malignant | 32.1% | 0.91 | 0.28 |
| NSCLC_38242124__IMC__88_A6,16 | Lung | Primary cancer | 3,966 | Tumor/Malignant | 43.1% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__88_A6,3 | Lung | Primary cancer | 4,381 | Tumor/Malignant | 60.7% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__88_A6,4 | Lung | Primary cancer | 2,808 | Stromal | 29.1% | 0.95 | 0.21 |
| NSCLC_38242124__IMC__88_A6,5 | Lung | Primary cancer | 3,515 | Tumor/Malignant | 38.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_A6,6 | Lung | Primary cancer | 1,767 | Other | 22.4% | 0.45 | 0.92 |
| NSCLC_38242124__IMC__88_A6,8 | Lung | Primary cancer | 3,256 | Tumor/Malignant | 44.1% | 0.94 | 0.16 |
| NSCLC_38242124__IMC__88_A6,9 | Lung | Primary cancer | 3,337 | Tumor/Malignant | 82.4% | 0.99 | 0.05 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A5,2 | Lung | Primary cancer | 4,071 | Tumor/Malignant | 29.9% | 0.50 | 0.87 |
| NSCLC_38242124__IMC__88_A5,3 | Lung | Primary cancer | 4,953 | Lymphoid | 30.8% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__88_A5,4 | Lung | Primary cancer | 2,985 | Stromal | 25.8% | 0.90 | 0.31 |
| NSCLC_38242124__IMC__88_A5,5 | Lung | Primary cancer | 1,331 | Other | 24.1% | 0.38 | 0.97 |
| NSCLC_38242124__IMC__88_A5,6 | Lung | Primary cancer | 2,916 | Lymphoid | 45.6% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__88_A5,8 | Lung | Primary cancer | 4,174 | Tumor/Malignant | 39.8% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__88_A5,9 | Lung | Primary cancer | 2,590 | Tumor/Malignant | 81.0% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_A6,1 | Lung | Primary cancer | 4,214 | Tumor/Malignant | 43.8% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__88_A6,10 | Lung | Primary cancer | 2,671 | Tumor/Malignant | 52.0% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__88_A6,11 | Lung | Primary cancer | 3,657 | Tumor/Malignant | 75.0% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_A6,12 | Lung | Primary cancer | 3,303 | Tumor/Malignant | 42.4% | 0.98 | 0.12 |
| NSCLC_38242124__IMC__88_A6,13 | Lung | Primary cancer | 816 | Stromal | 30.9% | 0.85 | 0.38 |
| NSCLC_38242124__IMC__88_A6,15 | Lung | Primary cancer | 3,624 | Tumor/Malignant | 29.4% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__88_A6,16 | Lung | Primary cancer | 3,966 | Tumor/Malignant | 53.7% | 0.93 | 0.23 |
| NSCLC_38242124__IMC__88_A6,3 | Lung | Primary cancer | 4,381 | Tumor/Malignant | 53.8% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__88_A6,4 | Lung | Primary cancer | 2,808 | Tumor/Malignant | 43.3% | 0.88 | 0.37 |
| NSCLC_38242124__IMC__88_A6,5 | Lung | Primary cancer | 3,515 | Tumor/Malignant | 56.4% | 0.93 | 0.19 |
| NSCLC_38242124__IMC__88_A6,6 | Lung | Primary cancer | 1,767 | Tumor/Malignant | 21.2% | 0.34 | 1.13 |
| NSCLC_38242124__IMC__88_A6,8 | Lung | Primary cancer | 3,256 | Tumor/Malignant | 45.6% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__88_A6,9 | Lung | Primary cancer | 3,337 | Tumor/Malignant | 60.0% | 0.99 | 0.03 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A5,2 | Lung | Primary cancer | 4,071 | Tumor/Malignant cell | 31.6% | 0.82 | 0.42 |
| NSCLC_38242124__IMC__88_A5,3 | Lung | Primary cancer | 4,953 | B cell | 35.2% | 0.47 | 0.71 |
| NSCLC_38242124__IMC__88_A5,4 | Lung | Primary cancer | 2,985 | Fibroblast | 39.0% | 0.83 | 0.44 |
| NSCLC_38242124__IMC__88_A5,5 | Lung | Primary cancer | 1,331 | Fibroblast | 26.1% | 0.57 | 0.84 |
| NSCLC_38242124__IMC__88_A5,6 | Lung | Primary cancer | 2,916 | B cell | 37.6% | 0.90 | 0.32 |
| NSCLC_38242124__IMC__88_A5,8 | Lung | Primary cancer | 4,174 | Tumor/Malignant cell | 66.2% | 0.88 | 0.30 |
| NSCLC_38242124__IMC__88_A5,9 | Lung | Primary cancer | 2,590 | Tumor/Malignant cell | 81.0% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_A6,1 | Lung | Primary cancer | 4,214 | Tumor/Malignant cell | 56.1% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__88_A6,10 | Lung | Primary cancer | 2,671 | Tumor/Malignant cell | 71.5% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__88_A6,11 | Lung | Primary cancer | 3,657 | Tumor/Malignant cell | 79.1% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__88_A6,12 | Lung | Primary cancer | 3,303 | Tumor/Malignant cell | 47.8% | 0.96 | 0.18 |
| NSCLC_38242124__IMC__88_A6,13 | Lung | Primary cancer | 816 | Fibroblast | 35.5% | 0.79 | 0.50 |
| NSCLC_38242124__IMC__88_A6,15 | Lung | Primary cancer | 3,624 | Tumor/Malignant cell | 33.9% | 0.90 | 0.32 |
| NSCLC_38242124__IMC__88_A6,16 | Lung | Primary cancer | 3,966 | Tumor/Malignant cell | 53.4% | 0.93 | 0.23 |
| NSCLC_38242124__IMC__88_A6,3 | Lung | Primary cancer | 4,381 | Tumor/Malignant cell | 62.0% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__88_A6,4 | Lung | Primary cancer | 2,808 | Tumor/Malignant cell | 44.8% | 0.87 | 0.39 |
| NSCLC_38242124__IMC__88_A6,5 | Lung | Primary cancer | 3,515 | Tumor/Malignant cell | 55.8% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__88_A6,6 | Lung | Primary cancer | 1,767 | T cell | 23.3% | 0.27 | 1.19 |
| NSCLC_38242124__IMC__88_A6,8 | Lung | Primary cancer | 3,256 | Tumor/Malignant cell | 45.7% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__88_A6,9 | Lung | Primary cancer | 3,337 | Tumor/Malignant cell | 82.8% | 0.99 | 0.05 |